Medical Drugs News
-
Alfa Chemistry: Custom Design Takes Organs-On-Chips to the Next Level
In a groundbreaking move to revolutionize the field of biomedical research, Alfa Chemistry recently announced the launch of its highly anticipated custom organs-on-chips service. This cutting-edge technology provides scientists and researchers with an innovative platform to study human organs in a way that was previously impossible, promising to accelerate drug discovery, reduce the need for ...
-
Accelerating Drug Development with CD ComputaBio's Advanced Drug Design and CADD Solutions
CD ComputaBio, a reputable computational service provider in the field of biology, is dedicated to supporting research and trials by offering access to the latest software, technologies, and expertise at competitive prices and with fast turnaround times for researchers. Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with ...
-
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has launched a new line of Locust Bean Gum with advanced technical platforms to help scientists advance biopharmaceutical research. Over the past few decades, researchers have been working on developing delivery systems that can reduce side effects while improving efficacy. Natural polymers are ...
-
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has recently launched its new line of PLGA-based drug delivery systems for in vitro and in vivo applications, including biocompatible and biodegradable PLGA nanoparticles with different surface modifications (e.g., COOH groups, methoxy PEG, and PEG-azide). In recent years, the development of nanotechnology ...
-
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new reagent solutions for herpesvirus research, including a range of Human Herpesviruses Antibodies designed to help researchers better understand the structure of Herpesvirus entry and develop new treatments and prevention strategies. The Herpesviridae are a large family ...
-
CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications
CD Formulation, a leading provider of innovative pharmaceutical formulation services, has recently launched a comprehensive range of microsphere and microneedle solutions for pharmaceutical and biotech applications. The newly introduced solutions are focused on long-acting controlled-release microspheres and phase-transition microneedle patches, to meet the growing demand for novel ...
-
Creative Enzymes Introduces a Range of Lactobacillus Strains with Enhanced Benefits
Creative Enzymes, a leading provider of innovative enzymes and probiotic solutions, is proud to introduce a range of Lactobacillus strains with enhanced benefits that are designed to revolutionize the way we approach gut health. This high-quality probiotic powder not only offers a wide range of health benefits but also opens up new opportunities for the food and pharmaceutical industries. In ...
-
Creative Enzymes Leads the Way with Innovative PETase Solutions for Efficient Plastic Recycling
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials to provide customers with as many enzyme services and products as possible. With the technical escalation of its enzyme platform, the company is proud to launch advanced PETases (polyethylene terephthalate hydrolase) for improved plastic recycling. Polyethylene ...
-
Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years
Data from pivotal PHOTON trial demonstrate long term efficacy of aflibercept 8 mg with extended intervals comparable to Eylea (aflibercept 2 mg) at fixed 8-weekly dosing over two years Patients assigned to a 16-week dosing regimen at baseline received a mean of 7.8 injections (6 fewer than Eylea) Safety profile of aflibercept 8 mg in diabetic macular edema (DME) remains comparable to Eylea ...
By Bayer AG
-
CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles
Microsphere formulation has been highlighted as a promising dosage form in clinical practice due to its ability to significantly improve patient convenience and compliance. As a trustworthy partner in the field of pharmaceutical formulation, CD Formulation has newly introduced a range of raw materials for the production of microspheres and microneedles, which are highly expected to advance ...
-
CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing
CD Genomics, a global leader in transcriptomics solutions, unveils its mature Nanopore Direct RNA Sequencing service that can propel transcriptomics research to new heights. With this service, CD Genomics empowers researchers to unlock the full potential of their studies with unrivalled precision and efficiency. Harnessing the power of Oxford Nanopore sequencing technology, this revolutionary ...
By CD Genomics
-
CD Genomics Introduces Advanced Exosomal RNA Sequencing Service for Enhanced Molecular Insights
CD Genomics, a leading provider of transcriptomics sequencing solutions, is pleased to announce the launch of its Exosomal RNA Sequencing service. This innovative service is set to provide researchers with comprehensive and accurate analysis of exosomal RNA, facilitating a deeper understanding of their functional significance in various biological processes. Exosomes, small extracellular ...
By CD Genomics
-
Alfa Chemistry Unveils Its Latest Offering of Bioactive Molecules for Scientific Breakthroughs
The US-based chemical supplier Alfa Chemistry recently announced the availability of a range of bioactive molecules for scientific research, including activators, agonists, antagonists, and inhibitors. Bioactive molecules are compounds that can interact with biological systems, such as proteins, enzymes, and the human body, and produce a physiological response. They play a crucial role in the ...
-
CD Genomics Introduces Complete Plasmid DNA Sequencing Service Accelerating Genetic Research
CD Genomics, a globally recognized leader in genomics services, has recently unveiled its Complete Plasmid DNA Sequencing service, empowering researchers with cutting-edge solutions for genetic exploration. This service aims to provide scientists in various fields, such as molecular biology, genetics, and gene engineering, with exceptional support, enabling them to gain comprehensive insights ...
By CD Genomics
-
Creative Proteomics Revolutionizes DNA-Protein Interaction Studies with Cutting-Edge DNA Pull Down Service
Creative Proteomics, a leading provider of proteomics and metabolomics services, proudly unveils its DNA Pull Down Service, providing scientists with an unrivalled tool to unravel the mysteries of DNA-protein interactions. This revolutionary service promises to expedite breakthroughs in gene regulation, disease mechanisms, and drug discovery, catering to the ever-growing demands of the scientific ...
-
Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research
Creative Proteomics, a leading provider of proteomics, metabolomics, and bioinformatics services, is pleased to announce the launch of its new Crotonylation Proteomics Analysis Service. This service is designed to provide researchers with a comprehensive and in-depth analysis of crotonylation, a newly discovered post-translational modification (PTM) of lysine residues. Crotonylation, a recently ...
-
Creative Proteomics Expands Proteomics Services with Launch of N-Terminal Edman Degradation Service
Creative Proteomics, an integrated CRO company committed to providing a full range of services in order to support various proteome-related research projects, is excited to announce the launch of its N-Terminal Edman Degradation Service. This service is designed to accelerate protein research and provide researchers with robust solutions for amino acid sequence analysis. Protein research has ...
-
Glass and Plastic Packaging Materials Diversified at CD Formulation
CD Formulation, a leading CRO service provider in the pharmaceutical formulation industry, has recently announced its latest expansion into the realm of glass and plastic packaging materials. This move is made because the company plans to further diversify its product lineup, in the hope to offer clients even more options. For many manufacturers either in the health care or pharmaceutical ...
-
Ovivo’s Women for Water presents: Astrid Kloosterman
Career Progression Through Adaptability and Education Choosing a career path can be a daunting task, and it’s not uncommon for people to change their minds before discovering their true aspiration. However, staying determined to find your passion is essential to finding the career you will love. Astrid is a great example of how a person can find their true calling and choose to pursue ...
-
Editas Medicine Announces Positive Initial EDIT-301 Safety And Efficacy Data From The First Four Patients Treated In The RUBY Trial And The First Patient Treated In The EdiTHAL Trial
Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced positive initial safety and efficacy data from the first four patients with sickle cell disease (SCD) treated with EDIT-301 in the RUBY trial and from the first transfusion-dependent beta thalassemia patient treated in the EdiTHAL trial. The RUBY trial data will be presented in an oral presentation at ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you